Moods Disorders Completed Phase 4 Trials for Minocycline (DB01017)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02263872Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled TrialTreatment